Prevalence of Trachoma in Bauchi State, Nigeria: Results of 20 Local Government Area-Level Surveys. by Mpyet, Caleb et al.
Mpyet, C; Muhammad, N; Adamu, MD; Muazu, H; Umar, MM;
Abdull, M; Alada, J; Goyol, M; Onyebuchi, U; Olamiju, F; Isiyaku,
S; William, A; Nwobi, BC; Willis, R; Flueckiger, RM; Pavluck, A;
Chu, BK; Olobio, N; Solomon, AW (2016) Prevalence of Trachoma in
Bauchi State, Nigeria: Results of 20 Local Government Area-Level
Surveys. Ophthalmic epidemiology, 23 (sup1). pp. 39-45. ISSN
0928-6586 DOI: https://doi.org/10.1080/09286586.2016.1238945
Downloaded from: http://researchonline.lshtm.ac.uk/4398314/
DOI: 10.1080/09286586.2016.1238945
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=iope20
Ophthalmic Epidemiology
ISSN: 0928-6586 (Print) 1744-5086 (Online) Journal homepage: http://www.tandfonline.com/loi/iope20
Prevalence of Trachoma in Bauchi State, Nigeria:
Results of 20 Local Government Area-Level Surveys
Caleb Mpyet, Nasiru Muhammad, Mohammed Dantani Adamu, Habila
Muazu, Murtala Muhammad Umar, Mohammed Abdull, Joel Alada, Musa
Goyol, Uwaezuoke Onyebuchi, Francisca Olamiju, Sunday Isiyaku, Adamani
William, Benjamin C. Nwobi, Rebecca Willis, Rebecca Mann Flueckiger, Alex
Pavluck, Brian K. Chu, Nicholas Olobio & Anthony W. Solomon
To cite this article: Caleb Mpyet, Nasiru Muhammad, Mohammed Dantani Adamu, Habila Muazu,
Murtala Muhammad Umar, Mohammed Abdull, Joel Alada, Musa Goyol, Uwaezuoke Onyebuchi,
Francisca Olamiju, Sunday Isiyaku, Adamani William, Benjamin C. Nwobi, Rebecca Willis, Rebecca
Mann Flueckiger, Alex Pavluck, Brian K. Chu, Nicholas Olobio & Anthony W. Solomon (2016)
Prevalence of Trachoma in Bauchi State, Nigeria: Results of 20 Local Government Area-Level
Surveys, Ophthalmic Epidemiology, 23:sup1, 39-45, DOI: 10.1080/09286586.2016.1238945
To link to this article:  https://doi.org/10.1080/09286586.2016.1238945
Published with license by Taylor & Francis©
2016 Caleb Mpyet, Nasiru Muhammad,
Mohammed Dantani Adamu, Habila Muazu,
Murtala Muhammad Umar, Mohammed
Abdull, Joel Alada, Musa Goyol, Uwaezuoke
Onyebuchi, Francisca Olamiju, Sunday
Isiyaku, Adamani William, Benjamin C.
Nwobi, Rebecca Willis, Rebecca Mann
Flueckiger, Alex Pavluck, Brian K. Chu,
Nicholas Olobio, and Anthony W. Solomon,
for the Global Trachoma Mapping Project.
Published online: 15 Nov 2016.
Submit your article to this journal Article views: 397
View related articles View Crossmark data
Citing articles: 4 View citing articles 
ORIGINAL ARTICLE
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ABSTRACT
Purpose: To determine the prevalence of trachomatous inflammation – follicular (TF) and trichiasis
in each of the 20 local government areas (LGAs) of Bauchi State, Nigeria.
Methods: We undertook a population-based prevalence survey in each LGA in Bauchi State,
employing the Global Trachoma Mapping Project methodology. We used a 2-stage, systematic
and quasi-random sampling strategy. Using probability proportional to size, we selected 25
clusters, in each of which 25 households were selected by random walk. All residents of selected
households 1 year and older were examined for TF, trachomatous inflammation – intense, and
trichiasis, using the World Health Organization simplified grading scheme.
Results: Only two LGAs in Bauchi State had TF prevalences in 1–9-year-olds over 5%, with none having
TF prevalences of 10% or greater. Only one LGA had a trichiasis prevalence in adults below the
elimination threshold; all the others had trichiasis at levels suggestive of public health significance. In
all 20 LGAs, more than 60%of households werewithin 1 kmof an improved source of water for hygiene.
Conclusion: Efforts need to be made in Bauchi State to provide trichiasis surgery in order to avert
trachomatous blindness. Water supplies needs to be sustained and good personal hygiene practices
assured so that elimination of trachoma as a public health problem will be achieved and sustained.
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Introduction
In Nigeria, 84% of cases of blindness are avoidable,
with trachoma responsible for 4% of blindness overall.1
Trachoma is the leading infectious cause of blindness
worldwide.2 It can be prevented by implementing the
SAFE strategy (surgery for trichiasis, antibiotics to clear
infection, and promotion of facial cleanliness and
environmental improvement to reduce transmission),
as recommended by the World Health Organization
(WHO).3 A prerequisite for launching SAFE interven-
tions is an understanding of the local prevalence of
disease; specifically the district-level prevalences of tra-
chomatous inflammation – follicular (TF) in children
aged 1–9 years, and trachomatous trichiasis in adults
aged 15 years and older. This helps to determine which
aspects of the SAFE strategy need to be undertaken in
each district.4
Bauchi State is located in north-eastern Nigeria; the
region with the highest burden of blindness in the
country.5 There has been no established trachoma con-
trol program and no comprehensive blindness preven-
tion program in the State, in part due to lack of data.
Surveys in neighboring Jigawa and Yobe States have
indicated that trachoma is a public health problem in
contiguous populations.6,7
Since Bauchi State is adjacent to known trachoma
endemic areas, we sought to determine the district-level
(local government area, LGA) prevalence of trachoma
throughout Bauchi, in order to provide government
and partners the necessary data required for the estab-
lishment of a trachoma control program, if required.
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This study was conducted as part of the Global
Trachoma Mapping Project (GTMP).
Materials and methods
Sample size calculations, field team training and certifica-
tion protocols, data collection procedures, data processing
and analysis techniques all followed GTMP standards,
which have been previously published.8 Version 2 of the
GTMP training system was used. As described elsewhere
(in a companion paper on GTMP outputs for Kano
State9), in Bauchi, for each LGA, we selected 25 house-
holds in each of 25 villages, chosen using a 2-stage,
systematic and quasi-random sampling strategy. In each
selected household, all residents aged 1 year and older
were invited to be examined by GTMP-certified10 graders
for signs of TF, trachomatous inflammation – intense and
trichiasis.11 We also collected data on household-level
access to water and sanitation, using a combination of
questioning adult residents and direct observation.8
Ethics
Following local-language explanation of survey goals
and procedures, we obtained verbal consent for exam-
ination from this mostly illiterate population, and
recorded it electronically in a smartphone application
(LINKS system).8,12 Individuals aged over 15 years gave
consent for their own participation, and for the parti-
cipation of children in their care. We offered partici-
pants who had clinical evidence of active trachoma two
tubes of 1% tetracycline ophthalmic ointment, and told
them or a carer how to apply it. Participants with
trichiasis were referred to the nearest trained trichiasis
surgeon for free lid surgery. Protocols were approved
by the Ethics Committee of the London School of
Hygiene & Tropical Medicine (reference 6319), the
National Health Research Ethics Committee of
Nigeria (NHREC/01/01/2007), and the Bauchi State
Health Research Ethics Committee (NREC/12/05/
2013/4). Bauchi State Ministry of Health also gave
administrative permission for the work to proceed.
Data analyses
As described previously,8 data were checked and cleaned by
the GTMP Data Manager (RW). To derive LGA-level pre-
valence estimates, we adjusted TF data for age of partici-
pants (in 1-year age bands), and number of participants per
cluster, and trichiasis data for age of participants (in 5-year
age bands), sex of participants, and number of participants
per cluster. The trichiasis backlog in each LGA was calcu-
lated by multiplying the prevalence estimate in persons
aged 15 years and older by 56% of the total population in
the LGA (as determined in themost recent census), because
56% of the Nigerian population is 15 years and older.13
Results
Fieldwork was undertaken from December 2013 to
February 2014. In Bauchi State as a whole, a total of
75,843 residents were enumerated in selected house-
holds; 71,599 (94%) people were examined, 2841 (4%)
were absent on the day that field teams visited, 1348
(2%) refused examination, and 55 (0.1%) could not be
examined for various other reasons. The age range of
persons enumerated ranged from 1 year to over 100
years. More females (38,888, 54.3%) were examined
than males (32,711, 45.7%; Table 1).
We examined a total of 23,626 children aged 1–9 years.
Of these, 12,065 (51.1%) were male. The state-wide crude
prevalence of TF in 1–9-year-old males was 1.5% (95%
confidence interval, CI, 1.3–1.7%), which was also the
prevalence in 1–9-year-old females (odds ratio 1.0, 95%
CI 0.8–1.2; p = 1.0). The age-adjusted LGA-level preva-
lences of TF are shown in Table 2 and Figure 1.
A total of 31,444 persons aged 15 years and older
were examined. Of these, 12,835 (40.8%) were male.
The state-wide crude prevalence of trichiasis was 1.9%
(95% CI 1.8–2.1%). In males aged ≥15 years crude
trichiasis prevalence was 1.4% (95% CI 1.2–1.6%), in
females in the same age range it was 2.2% (95% CI 2.0–
2.5%). This difference in trichiasis prevalence between
adult females and adult males was statistically signifi-
cant (odds ratio 1.6, 95% CI 1.3–1.9; p < 0.001). Table 1
and Figure 2 show the LGA-level age- and sex-adjusted
prevalences of trichiasis.
Two LGAs (Shira and Tafawa Balewa) had TF pre-
valences between 5% and 9.9%. No LGAs had TF pre-
valences ≥10%. Trichiasis prevalences ranged between
0.1% (Das) and 3.3% (Zaki).
With a population (according to the most recent
census14) of over 4 million people, there is an estimated
trichiasis surgery backlog of 28,559 people in Bauchi
Table 1. Age and sex distribution of participants, Global
Trachoma Mapping Project, Bauchi State, Nigeria, 2013–2014.
Age group (years) Female, n (%) Male, n (%) Total, n (%)
1–10 14,544 (48.9) 15,211 (51.1) 29,755 (41.6)
11–20 7583 (58.9) 5289 (41.1) 12,872 (18.0)
21–30 7397 (71.8) 2904 (28.2) 10,301 (14.3)
31–40 4177 (58.2) 2998 (41.8) 7175 (10.0)
41–50 2492 (50.5) 2444 (49.5) 4936 (6.9)
51–60 1380 (41.9) 1912 (58.1) 3292 (4.6)
61–70 885 (41.8) 1232 (58.2) 2117 (3.0)
71–80 345 (37.8) 568 (62.2) 913 (1.3)
80+ 85 (35.7) 153 (64.3) 238 (0.3)
Total 38,888 (54.3) 32,711 (45.7) 71,599 (100)
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Table 2. Local government area-level prevalences of trachomatous inflammation – follicular (TF) and trichiasis, Global Trachoma
Mapping Project, Bauchi State, Nigeria, 2013–2014.
Local government area
Age-adjusted TF prevalence in 1–9-year-olds, %
(95% confidence interval)
Age- and sex-adjusted trichiasis prevalence in those ≤ 15 years, %
(95% confidence interval)
Alkaleri 0.7 (0.3–1.1) 0.7 (0.2–1.4)
Bauchi 0.5 (0.1–0.9) 0.4 (0.2–0.6)
Bogoro 2.5 (1.4–3.4) 0.7 (0.3–1.5)
Damban 0.0 (0.0–0.0) 0.7 (0.3–1.2)
Darazo 2.3 (1.2–3.2) 1.2 (0.8–1.7)
Dass 0.1 (0.0–0.2) 0.1 (0.1–0.2)
Gamawa 1.4 (0.7–2.4) 1.9 (1.3–2.7)
Ganjuwa 1.2 (0.5–1.8) 0.9 (0.6–1.2)
Giade 0.1 (0.0–0.1) 0.9 (0.5–1.3)
Itas/Gadau 4.5 (3.0–6.5) 1.6 (1.0–2.2)
Jamaare 2.3 (1.2–3.6) 2.1 (1.4–3.0)
Katagum 0.9 (0.5–1.6) 2.0 (1.6–2.6)
Kirfi 1.3 (0.6–2.1) 2.3 (1.6–2.9)
Misau 0.0 (0.0–0.0) 0.5 (0.2–0.8)
Ningi 0.0 (0.0–0.0) 1.4 (0.7–2.4)
Shira 7.5 (5.4–9.9) 0.5 (0.2–0.8)
Tafawa Balewa 7.3 (5.3–9.2) 0.2 (0.1–0.4)
Toro 0.1 (0.0–0.2) 0.2 (0.1–0.5)
Warji 2.5 (1.1–4.2) 1.6 (1.0–2.4)
Zaki 3.1 (1.6–4.8) 3.3 (1.9–5.3)
Figure 1. Prevalence of trachomatous inflammation – follicular (TF) in 1–9-year-old children, by local government area, Global
Trachoma Mapping Project, Bauchi State, Nigeria, 2013–2014.
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State, with at least 23,377 surgeries needing to be per-
formed to reach the WHO target for the trichiasis
component of “elimination of trachoma as a public
health problem”14 in each LGA of Bauchi State. Zaki
has the greatest need for provision of trichiasis surgery
amongst all Bauchi LGAs (Table 3).
Access to an improved source of water for hygiene
purposes (defined as one which by nature of its con-
struction and proper use adequately protects its con-
tained water from outside contamination) is generally
good in Bauchi State. In all 20 LGAs, >60% of house-
holds had access to an improved water source within 1
km, and in 15 LGAs (all except Bogoro, Gamawa, Itas-
Gadau, Missau and Tafawa Balewa) this was true for
>80% of households. Access to improved latrines defined
as any latrine facility that hygienically separates human
excreta from human contact ranged from approximately
3% in Bogoro to 99% in Missau LGA (Table 4).
Discussion
In Bauchi State, there is a high prevalence of trichiasis,
the potentially blinding stage of trachoma. State-wide,
we estimate there are more than 28,000 people with
trichiasis; if left untreated, this could progress in each
person to cause corneal damage and irreversible visual
impairment or blindness. To prevent this number of
people from potentially losing vision due to trachoma,
urgent scale-up of the surgery component of the SAFE
strategy is required. Particular attention should be
Figure 2. Prevalence of trichiasis in adults ≥15 years, by local government area, Global Trachoma Mapping Project, Bauchi State,
Nigeria, 2013–2014.
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directed to LGAs (such as Zaki, Katagum, Ningi, and
Gamawa) where there are particularly large numbers of
persons needing surgery. The trachoma program
should train15 and deploy more trichiasis surgeons to
these areas, while not neglecting the other LGAs,
because the current contingent of 10 active trichiasis
surgeons in Bauchi is inadequate for the size of the task
at hand. Deliberate efforts to provide trichiasis surgery
close to where people live,16 and to encourage female
trichiasis patients to present, are required. Women
usually have worse access to trichiasis surgery services,
are more afraid of surgery, and are less likely to have
been offered surgery in the past.17
Active trachoma is currently not at levels indicative of
a public health problem in Bauchi State, with only two
LGAs (Shira and Tafawa Balewa) having TF prevalences
in 1–9-year-olds of 5% or higher; these two LGAs may
benefit from a single round of azithromycin mass drug
administration.18 Given that access to improved water for
hygiene purposes is high in this state, emphasis on the “E”
component of the SAFE strategy here should include
maintenance of existing water sources, while continuing
to aim for 100% of households having proximate access to
water in all communities. Given the low prevalence of TF,
relatively high prevalence of TT, and absence of previous
specific trachoma control interventions, it is possible that
Table 3. Local government area-level estimates of trichiasis surgery backlog, Global Trachoma Mapping Project, Bauchi State,
Nigeria, 2013–2014.
Local
government
area
Estimated total
population, n
Trichiasis prevalence in
those ≥15 years, %
Estimated trichiasis
surgery backlog, n
People to be offered trichiasis surgery to achieve the trichiasis component
of WHO “elimination of trachoma as a public health problem”, n
Bauchi 493,730 0.4 1125 572
Bogoro 83,809 0.7 347 253
Damban 150,212 0.7 599 431
Darazo 249,946 1.2 1728 1448
Dass 90,114 0.1 71 0
Gamawa 284,411 1.9 3039 2721
Ganjuwa 278,471 0.9 1347 1035
Giade 156,022 0.9 804 630
Itas/Gadau 228,527 1.6 1997 1741
Jama’are 117,482 2.1 1367 1235
Katagum 293,020 2.0 3339 3011
Kirfi 145,636 2.3 1849 1686
Misau 261,410 0.5 662 370
Ningi 385,997 1.4 3101 2668
Shira 233,999 0.5 627 365
Tafawa
Balewa
221,310 0.2 279 31
Toro 346,000 0.2 474 86
Warji 114,983 1.6 1006 877
Zaki 189,703 3.3 3489 3277
Total 4,653,066 28,559 23,377
WHO, World Health Organization.
Table 4. Household access to washing water and improved latrines, by local government area, Global Trachoma Mapping Project,
Bauchi State, Nigeria, 2013–2014.
Local government area Improved wash water access <1 km, % Improved wash water use, % Improved latrine access, %
Alkaleri 81.4 54.2 15.7
Bauchi 93.5 93.1 66.9
Bogoro 74.7 74.8 5.9
Darazo 89.9 89.7 49.2
Dass 95.9 96.1 68.4
Damban 93.7 93.4 21.7
Gamawa 62.6 62.6 20.9
Ganjuwa 99.8 99.8 10.6
Giade 98.9 98.7 87.0
Itas-Gadau 78.8 78.8 41.4
Jamaare 87.4 87.7 25.7
Katagum 95.8 95.8 64.3
Kirfi 100.0 63.8 2.7
Misau 69.0 68.8 99.0
Ningi 97.4 97.2 10.9
Shira 100.0 100.0 20.2
Tafawa Balewa 68.4 68.2 39.8
Toro 93.1 92.8 15.2
Warji 85.6 85.4 57.1
Zaki 83.3 83.3 7.0
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trachoma is already undergoing a secular trend towards
elimination in Bauchi.
There is also a need to increase access to improved
latrine facilities, with Kirfi, Bogoro and Zaki LGAs being
high on the priority list in this regard. There were only two
of 20 LGAs in which >80% of households had improved
latrine access. These data call for collaboration with water
and sanitation agencies to prioritize provision of latrines (or
other means of safe disposal of human feces), as part of
efforts to achieve United Nations sustainable development
goals.19 Latrine provision, in tandem with maintaining
good access to water, should greatly assist in eliminating
trachoma and other neglected tropical diseases in Bauchi.
Trachoma may be disappearing from Bauchi State, but
there is an urgent need for provision of high volume, high
quality, community-based trichiasis surgery, and mainte-
nance or further suppression of the (presumed) current low
transmission rate of ocular Chlamydia trachomatis infec-
tion. Elimination of trachoma as a public health problem
here could provide a template for action in similar areas of
Nigeria and beyond.
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